James Chalmers to Spike Glycoprotein, Coronavirus
This is a "connection" page, showing publications James Chalmers has written about Spike Glycoprotein, Coronavirus.
Connection Strength
0.006
-
ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jul 31; 21(1):691.
Score: 0.006